Cathay Biotech Inc (688065) — Working Capital to Net Assets Ratio
Cathay Biotech Inc (688065) has a Working Capital to Net Assets ratio of 44.9% as of June 2026. Working capital of CN¥9.68 Billion (current assets of CN¥11.96 Billion minus current liabilities of CN¥2.28 Billion) is measured against net assets of CN¥21.59 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 688065 days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cathay Biotech Inc Working Capital to Net Assets (2016–2025)
This chart shows how Cathay Biotech Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 44.9%, reflecting working capital of CN¥9.68 Billion against net assets of CN¥21.59 Billion CNY. For the complete balance sheet picture, see balance sheet size of Cathay Biotech Inc.
Annual Working Capital to Net Assets for Cathay Biotech Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cathay Biotech Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Cathay Biotech Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 21.6% | CN¥9.72 Billion | CN¥45.10 Billion | CN¥11.73 Billion | CN¥2.01 Billion | ▼ -8.0 pp |
| 2024 | 29.6% | CN¥4.47 Billion | CN¥15.10 Billion | CN¥7.39 Billion | CN¥2.92 Billion | ▲ +1.4 pp |
| 2023 | 28.2% | CN¥4.16 Billion | CN¥14.77 Billion | CN¥7.57 Billion | CN¥3.41 Billion | ▼ -18.7 pp |
| 2022 | 46.9% | CN¥7.05 Billion | CN¥15.04 Billion | CN¥8.48 Billion | CN¥1.42 Billion | ▼ -22.4 pp |
| 2021 | 69.3% | CN¥10.18 Billion | CN¥14.69 Billion | CN¥11.39 Billion | CN¥1.22 Billion | ▼ -0.5 pp |
| 2020 | 69.7% | CN¥8.01 Billion | CN¥11.48 Billion | CN¥8.44 Billion | CN¥434.77 Million | ▲ +33.8 pp |
| 2019 | 35.9% | CN¥1.67 Billion | CN¥4.64 Billion | CN¥2.71 Billion | CN¥1.04 Billion | ▲ +26.1 pp |
| 2018 | 9.8% | CN¥308.44 Million | CN¥3.16 Billion | CN¥1.82 Billion | CN¥1.51 Billion | ▲ +5.2 pp |
| 2017 | 4.6% | CN¥100.70 Million | CN¥2.20 Billion | CN¥898.92 Million | CN¥798.22 Million | ▼ -25.5 pp |
| 2016 | 30.1% | CN¥366.86 Million | CN¥1.22 Billion | CN¥791.81 Million | CN¥424.96 Million | — |